If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:236395-14-5
Source:India
Qualifications:-/-/-/-/-
Name | Eslicarbazepine acetate |
---|---|
Chinese name | 醋酸艾司利卡西平 |
Cas Number | 236395-14-5 |
Source | India |
Qualifications | -/-/-/-/- |
Eslicarbazepine acetate was launched in Europe in 2009 under the trade name Zebinix, and was approved for marketing by the FDA in 2013. Eslicarbazepine is a prodrug of S-licarbazepine acetate developed by Sunovion Pharma. It is a "third-generation" anti-epileptic drug. S-licarbazepine is the main active metabolite of oxcarbazepine, which can block voltage dependence. Oxcarbazepine and carbamazepine are the main first-line drugs for partial seizure epilepsy. Compared with oxcarbazepine, eslicarbazepine acetate is better tolerated and has clinical prospects and competition. The conditions are good, and it is predicted that the next few years will be a hot spot for antiepileptic drug imitation.
Hot Tags: eslicarbazepine acetate api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Lurasidone Hydrochloride API, Tetrabenazine API, Aprepitant Aprepitant API, Fulvestrant API, Ulipristal Acetate API, Paliperidone API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China